摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,6-Diaminopurin-9-yl)propan-2-yloxymethylphosphonic acid

中文名称
——
中文别名
——
英文名称
1-(2,6-Diaminopurin-9-yl)propan-2-yloxymethylphosphonic acid
英文别名
——
1-(2,6-Diaminopurin-9-yl)propan-2-yloxymethylphosphonic acid化学式
CAS
——
化学式
C9H15N6O4P
mdl
——
分子量
302.23
InChiKey
LWEKFDHXJHJYGB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.2
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    162
  • 氢给体数:
    4
  • 氢受体数:
    9

文献信息

  • Novel compounds and methods for therapy
    申请人:INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ACADEMY OF SCIENCES
    公开号:US20030109499A1
    公开(公告)日:2003-06-12
    Novel compounds are provided having formula (I) 1 where R 1 , R 2 , R 3 , R 4 , Z, X and * are defined herein. Also provided are antiviral methods for use and processes for synthesis of the compounds of formula (I).
    提供具有以下化学式(I)的新化合物: 其中 R 1 ,R 2 ,R 3 ,R 4 ,Z,X和*在此处定义。还提供了用于抗病毒方法和合成化合物(I)的过程。
  • NUCLEOSIDE PHOSPHONATE DERIVATIVES
    申请人:Or Yat Sun
    公开号:US20090274686A1
    公开(公告)日:2009-11-05
    The present invention discloses compounds of formula (I) or (II), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit, preventing or treating abnormal cellular proliferation and/or a viral infection, particularly by HIV, HCV or HBV. Consequently, the compounds of the present invention interfere with the replication cycle of a virus and are also useful as antiviral agents, or interfere with host cellular biochemical process and are also useful as antiproliferative agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from viral infection and/or cell proliferation. The invention also relates to methods of treating a viral infection and/or cell proliferation in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention relates to novel antiviral/anti-proliferative compounds represented herein above, pharmaceutical compositions comprising such compounds, and methods for the treatment or prophylaxis of viral infection in a subject in need of such therapy with said compounds.
    本发明揭示了化合物的公式(I)或(II),或其药学上可接受的盐、酯或前药:这些化合物抑制、预防或治疗异常细胞增殖和/或病毒感染,特别是HIV、HCV或HBV。因此,本发明的化合物干扰病毒的复制周期,同时也可用作抗病毒剂,或干扰宿主细胞的生化过程,同时也可用作抗增殖剂。本发明还涉及包含上述化合物的药物组合物,用于治疗患有病毒感染和/或细胞增殖的受试者。该发明还涉及通过给予包含本发明化合物的药物组合物来治疗受试者的病毒感染和/或细胞增殖的方法。本发明涉及上述新型抗病毒/抗增殖化合物,包括含有这些化合物的药物组合物,以及用于治疗或预防受试者的病毒感染的方法。
  • [EN] PYRIMIDINE COMPOUNDS HAVING PHOSPHONATE GROUPS AS ANTIVIRAL NUCLEOTIDE ANALOGS<br/>[FR] COMPOSÉS DE PYRIMIDINE À GROUPES PHOSPHONATE, EN TANT QU'ANALOGUES NUCLEOTIDIQUES ANTIVIRAUX
    申请人:ACAD OF SCIENCE CZECH REPUBLIC
    公开号:WO2004111064A1
    公开(公告)日:2004-12-23
    Novel compounds are provided having formula (I) where R1, R2, R3, R4, Z, X and * are defined herein. Also provided are antiviral methods for use and processes for synthesis of the compounds of formula (I).
    提供具有化学式(I)的新化合物,其中R1、R2、R3、R4、Z、X和*在此处定义。还提供了用于抗病毒的方法以及合成化合物(I)的过程。
  • 2'-Fluoronucleoside phosphonates as antiviral agents
    申请人:Shi Junxing
    公开号:US20070225249A1
    公开(公告)日:2007-09-27
    The present invention includes compounds and compositions of R -2′-fluoronucleoside phosphonates, as well as methods to treat HIV, HBV, HCV or abnormal cellular proliferation comprising administering said compounds or compositions.
    本发明涉及R-2'-氟核苷酸膦酸酯化合物和组合物,以及使用该化合物或组合物治疗HIV、HBV、HCV或异常细胞增殖的方法。
  • [EN] ANTIRETROVIRAL ENANTIOMERIC NUCLEOTIDE ANALOGS<br/>[FR] ANALOGUES DE NUCLEOTIDES ENANTIOMERES ANTIRETROVIRAUX
    申请人:INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC
    公开号:WO1994003467A2
    公开(公告)日:1994-02-17
    (EN) Resolved enantiomers of formulae (IA) and (IB) wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.(FR) Des énantiomères dédoublés des formules (IA) et (IB) où B est une base purique ou pyrimidique, ou bien des analogues aza et/ou désaza de ceux-ci sont utiles dans des compositions pharmaceutiques antivirales pour traiter des infections rétrovirales.
    (中文) 公式(IA)和(IB)的旋光异构体,其中B是嘌呤或嘧啶碱基或其氮杂环和/或去氮杂环衍生物,可用于抗病毒药物组合物中,用于治疗逆转录病毒感染。
查看更多